Enhancing Prospective Thinking in Early Recovery
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 500
- 试验地点
- 2
- 主要终点
- Increased Length of Abstinence
研究概览
简要总结
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question[s] this trial aims to answer are:
Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- Single (Participant)
盲法说明
All study participants are randomly assigned to a group prior to study enrollment. Participants will not be made aware of their group assignment.
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Abstinence between ≥14 days and ≤1 year
- •Verbal endorsement of commitment to recovery
- •Outpatient
- •Psychotropic drugs for SUD-comorbidity
- •Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit
- •English comprehension
排除标准
- •Unstable medical disorders
- •Habitual drug use
- •Mu-opioid drugs
- •Smell/taste disorders
- •Unstable psychiatric conditions
- •Extravagant/elaborate face tattoos
研究组 & 干预措施
Virtual Reality
Participants in this arm will receive the following interventions:
Virtual Reality Park Virtual Reality Avatar
干预措施: Virtual Reality (Device)
Treatment As Usual
Participants in this arm will receive the following interventions:
Virtual Reality Park
干预措施: Virtual Reality (Device)
结局指标
主要结局
Increased Length of Abstinence
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase the length of abstinence periods.
Future Time Perspective with the Delayed Discounting Behavioral Task and Future Self Continuity Questionnaire
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase future time perspective.
Reduced Use of Drug Using Days
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit
The Virtual Reality Avatar experience will reduce drug using days.
Increased (overall) Abstinence
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase abstinence.
Delayed Reward Preference with the Delayed Discounting Behavioral Task
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit.
The Virtual Reality Avatar experience will increase preference for delayed rewards.
Future Self-identification with Future Self Continuity Questionnaire
时间窗: Day 2-Study Day Visit; 30-day Follow-up Visit; 6-month Follow-up Visit
The Virtual Reality Avatar experience will increase future self-identification.
次要结局
未报告次要终点
研究者
Brandon G. Oberlin, PhD
Assistant Professor
Indiana University